Navigation Links
Vomiting in Medical News

New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies

... (1.7 percent for women 2.1 percent in men) and vomiting (1.4 percent in women and 2.1 percent in men). ... headache (5%), abdominal pain (4%), nausea (3%), vomiting (2%), and rash (2%). In ... nausea (7%), rash (6%), abdominal pain (5%), vomiting (4%), asthenia (3%), headache (2%), abdominal ...

Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer

... percent), stomatitis (41 percent vs 15 percent), vomiting (33 percent vs 44 percent), diarrhea (21 percent ... 40 percent), diarrhea (46 percent vs 39 percent), vomiting (32 percent vs 22 percent), constipation (31 ... fever (8 percent), alopecia (9 percent), vomiting (8 percent), diarrhea (5 percent), and stomatitis ...

Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers

... a drug approved in the U.S. for nausea, vomiting and heartburn poses no significant risks for the ... cases, as it is an "off-label" use for nausea and vomiting during pregnancy. The findings of this very ... the drug is given to women to relieve nausea and vomiting during pregnancy." Between 50 percent to 80 ...

Drugs against winter vomiting disease one step closer

... The virus that causes winter vomiting disease invades cells by attaching to particular ... epidemics caused by the virus. Winter vomiting disease is an infectious inflammation of the ... The thesis describes how the virus for winter vomiting disease can attach to cells by binding to special ...

Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports

... (9%; 8%), diarrhea (8%; 9%), rash (8%; 9%), vomiting (9%; 8%) and myalgia (6%; 4%) were reported among ... (2%; 1%), diarrhea (3%; 1%), rash (3%; 0%) and vomiting (2%; 1%) were reported among patients receiving ... (57%; 55%), rash and related terms (56%; 70%) and vomiting (37%; 41%)*. The majority of both Gleevec ...

American Society of Anesthesiologists (ASA) - Myths About 'Never Ending Pursuit of Patient Safety and Satisfaction' Debunked

... Level I validation for Postoperative Nausea and vomiting (PONV) CORONA DEL MAR, Calif., March 11 ... satisfaction was highest when postoperative vomiting did not happen. Propofol ketamine (PK) ... recognized names in postoperative nausea and vomiting (PONV). When presented with the means (and ...

More>>

Vomiting in Medical Technology

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... for experiencing these side effects. Nausea and vomiting are uncomfortable and bothersome and can have an ... and significant reduction in nausea and/or vomiting compared to oxycodone IR. Results from the ... to oxycodone IR, the incidence of nausea and/or vomiting was significantly lower with tapentadol IR 50-mg: ...

Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer

... (46% vs 63%), stomatitis (41% vs 15%), vomiting (33% vs 44%), diarrhea (21% vs 35%), ... nausea (48% vs 40%), diarrhea (46% vs 39%), vomiting (32% vs 22%), constipation (31% vs 31%), ... asthenia (7%), fever (8%), alopecia (9%), vomiting (8%), diarrhea (5%), and stomatitis (5%) ...

Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma

... (including anorexia) (each 36%), pyrexia (34%), vomiting (33%), anemia (29%), edema (23%), headache, ... pneumonia (7%), pyrexia (6%), diarrhea (5%), vomiting (4%), and nausea, dehydration, dyspnea and ... neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% ...

Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients

... (including anorexia) (each 36%), pyrexia (34%), vomiting (33%), anemia (29%), edema (23%), ... pneumonia (7%), pyrexia (6%), diarrhea (5%), vomiting (4%), and nausea, dehydration, dyspnea ... neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% ...

CHMP Recommends Approval in the European Union (EU) for New Options for Patients With Certain Primary Brain Tumors

... 69%, 55%; fatigue 54%, 61%; nausea 36%, 49%; vomiting 20%, 29%; anorexia 19%, 27%; headache 19%, 23%; ... respectively, were fatigue 7%, 9% nausea; 1%, 1%; vomiting <1%, 2%; anorexia 1%, 1%; headache 2%, 4%; ... and overall, respectively were: nausea 10%, 53%; vomiting 6%, 42%; headache 6%, 41%; fatigue 4%, 34%; ...

Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients

... (including anorexia) (each 36%), pyrexia (34%), vomiting (33%), anemia (29%), edema (23%), ... (7%), pyrexia (6%), diarrhea (5%), vomiting (4%), and nausea, dehydration, dyspnea and ... neuralgia (36% vs 1%), leukopenia (33% vs 30%), vomiting (33% vs 16%), pyrexia (29% vs 19%), fatigue (29% ...

More>>

Vomiting in Medical Products

Programmer System (Enterra™ Therapy)

Description:... Therapy is indicated for the treatment of chronic nausea and vomiting associated with gastroparesis when conventional drug therapies are not ... In some patients, this condition results in severe, chronic nausea and vomiting that cannot be adequately controlled by available drugs. These patients ...
Company:Medtronic Gastroenterology

Medtronic ITREL 3 Model 7425G Neurostimulator (Enterra™ Therapy)

Description:... Therapy is indicated for the treatment of chronic nausea and vomiting associated with gastroparesis when conventional drug therapies are not ... In some patients, this condition results in severe, chronic nausea and vomiting that cannot be adequately controlled by available drugs. These patients ...
Company:Medtronic Gastroenterology

Medtronic Model 4351 Lead (Enterra™ Therapy)

Description:... Therapy is indicated for the treatment of chronic nausea and vomiting associated with gastroparesis when conventional drug therapies are not ... In some patients, this condition results in severe, chronic nausea and vomiting that cannot be adequately controlled by available drugs. These patients ...
Company:Medtronic Gastroenterology

Auro Green

Description:... Aurogreen is a safe dye with only a minor side - effect like iodide allergy reported with its clinical use. It is safer than fluorescein sodium. vomiting and nausea are extremely uncommon during ICG angiography. No complications were reported in a study using intravenous ICG doses of 150 to 200 ....
Company:Aurolab
Vomiting in Medical Definition

Pathology

... v • d • e Health science - Medicine - Gastroenterology (primarily K20-K93 ) Esophagus Halitosis - Nausea - vomiting - Heartburn - GERD - Achalasia - Esophageal cancer - Esophageal varices Stomach Peptic ulcer - Abdominal pain - Stomach ...
Vomiting in Medical Dictionary

Abdominal Pain

... as an infection (often with diarrhea and vomiting ), a reaction to a medication, lactose ... , or food Black, tarry stools Nausea and vomiting Bloated feeling after meals Weakness ... right lower side of the abdomen Nausea vomiting Abdominal swelling Pain when the right ...

Acidosis

... is potentially fatal. Symptoms include nausea , vomiting , fatigue , and shortness of breath. The use of ... ) or alkalosis (for example, caused by excess vomiting ) can affect blood potassium . metabolic ... Stomach ) Hiatal Hernia (Hiatus Hernia ) vomiting ( Emesis ) Indigestion ( Dyspepsia ) ...

Appetite

... loss. Headache . Diarrhea , nausea , and vomiting . Abnormal fat distribution on the body. ... changes in sense of taste or smell nausea / vomiting diarrhea lactose intolerance ... consisting of weakness , loss of appetite , vomiting , and diarrhea . The characteristic signs and ...

Belching

... : ثابت ، بشك" مميت مع غثيان وتهوع ا"تجشؤ فارغ. vomiting is difficult and provides no relief (from the ... symptoms of dysmotility, which include nausea , vomiting , excess belching , ... The sensation is ... into the throat, and may result in belching or vomiting . The pain usually begins 30 to 90 minutes ...

Binge eating

... with weight and shape, exercising and the use of vomiting and laxatives to reduce weight are often major ... include: ... binge eating self-induced vomiting inappropriate use of diuretics or laxatives ... characterized by binge eating followed by vomiting or use of laxatives. Usually caused by a variety ...

Blurred vision

... to regulate body temperature ) nausea or vomiting after meals ... Blurred vision in diabetes ... trouble swallowing, speaking, or breathing vomiting weak muscle s. Blurred vision is the main ... irritability and mood changes nausea and vomiting high levels of sugar in the blood when ...

More>>

Vomiting in Biological News

Treatment for extreme nausea, vomiting during pregnancy

... French . Montreal, May 6, 2009 Nausea and vomiting are telltale indicators of pregnancy, affecting ... hyperemisis gravidarum (HG), or severe nausea and vomiting of pregnancy, due to a FDA and Health Canada ... worked faster to quell symptoms of nausea and vomiting than droperidol. Importantly, they found no ...

Cause of mussel poisoning identified

... a long time that consumption of mussels and other bivalve shellfish can cause poisoning in humans, with symptoms ranging from diarrhea, nausea, and vomiting to neurotoxicological effects, including paralysis and even death in extreme cases. Although "shellfish poisoning" can also be caused by pathogenic ...

Genetic mutation causes familial susceptibility for degenerative brain disease

... for Disease Control, the disease includes lesions of the brain and brain stem. The disease progresses rapidly with symptoms that include cough, vomiting and diarrhea in combination with neurologic dysfunction, alteration of consciousness and seizures. The disease is often fatal, or it can lead to ...

Flowering plants speed post-surgery recovery

... problems are treated through the use of anesthetics and analgesics, but, if not properly administered, the drugs can have side effects ranging from vomiting and headaches to drug dependency or even fatality. It is therefore beneficial to patients and care providers to develop approaches that improve the ...

NIAID scientists to speak on range of infectious disease topics at major scientific meeting

... and immune-mediated diseases. Noroviruses, the highly contagious viruses that cause the episodes of acute gastroenteritis also known as winter vomiting disease (Kim Green, Ph.D.) The role of gut-dwelling commensal bacteria in producing the symptoms of Crohn's disease, a chronic inflammatory disease ...

Form of Crohn's disease traced to disabled gut cells

... In 2002, epidemiologists estimated that it affected 400,000 to 600,000 patients in North America. Symptoms include diarrhea, abdominal pain, vomiting and weight loss. The condition can lead to partial or full intestinal blockages, which can require surgical treatment. Research previously ...

More>>

Vomiting in Biological Technology

Strativa's New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA

... ondansetron ODFS for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic ... easy-to-administer option for managing nausea and vomiting associated with chemotherapy, radiotherapy and surgery." Nausea and vomiting is a common side effect associated with ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... nausea (46% vs 63%), stomatitis (41% vs 15%), vomiting (33% vs 44%), diarrhea (21% vs 35%), anorexia ... 18%), nausea (48% vs 40%), diarrhea (46% vs 39%), vomiting (32% vs 22%), constipation (31% vs 31%), ... (18%), asthenia (7%), fever (8%), alopecia (9%), vomiting (8%), diarrhea (5%), and stomatitis (5%) ...

Palonosetron Warrants Adequate Caloric Intake in Oncology Patients Receiving High Emetogenic Chemotherapy

... not only prevents chemotherapy-induced nausea and vomiting (CINV), but also allows adequate caloric intake ... to control chemotherapy-induced nausea and vomiting (CINV) episodes in patients treated with HEC ... the results demonstrated that patients with no vomiting and without nausea had a median daily food intake ...

FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting

... the prevention of chemotherapy-induced nausea and vomiting (CINV). ALOXI Capsules 0.5 mg for oral ... the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of ... and for the prevention of acute nausea and vomiting associated with initial and repeat courses of ...

FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer

... 2%), stomatitis/mucositis 29% (Grade 3/4: 6%), vomiting 29% (Grade 3/4: 1%), diarrhea 22% (Grade 3/4: ... (Grade 3/4: 3%), diarrhea 44% (Grade 3/4: 6%), vomiting 39% (Grade 3/4: 4%), myalgia/arthralgia 39% ... (Grade 3/4: 2%), diarrhea 39% (Grade 3/4: 9%), vomiting 24% (Grade 3/4: 2%), myalgia/arthralgia 5% (Grade ...

Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108

... pharmaceutical company dedicated to reducing opioid-induced nausea and vomiting (OINV) in opioid pharmaceuticals, announced today they successfully ... commercializing opioid drugs with minimal or no opioid-induced nausea and vomiting (OINV). Charleston Laboratories intends to enter into discovery and ...
Vomiting in Biological Products

Mouse Anti-Salmonella typhimurium Monoclonal Antibody, Unconjugated, Clone 6331 from GeneTex

Description:... S. Typhimurium does not cause as severe disease as S. Typhi, and is not normally fatal. The disease is characterized by diarrhea, abdominal cramps, vomiting and nausea, and generally lasts up to 7 days. Immunogen: Tissue / cell preparation. Specificity: Ab13630 is specific for Salmonella ....
Company:GeneTex
Vomiting in Biological Definition

Diabetes mellitus

... impending diabetic coma include polyuria, nausea, vomiting and abdominal pain , with lethargy and ... anorexia, abdominal distress, and eventually vomiting . The rising level of glucose increases the ... , and magnesium . Reduced fluid intake from vomiting combined with amplified urination produce ...

Ebola

... the joints), abdominal pains and headache . These symptoms progress to vomiting , diarrhea , oropharyngeal lesions , conjunctivitis , organ damage ... support, as he or she is probably dehydrated from losing fluids through vomiting and diarrhea. Finally, if the patient expires, the body should be properly ...

Colchicine

... with arsenic : symptoms start 2 to 5 hours after the toxic dose has been ingested and include burning in the mouth and throat, fever , vomiting , diarrhea , abdominal pain and kidney failure . Death from respiratory failure can follow. There is no antidote. Laboratory use In ...

Malaria

... was awarded the Nobel Prize for Physiology or Medicine in 1907 . Symptoms of malaria include fever , shivering , arthralgia (joint pain), vomiting , and convulsions . There may be the feeling of tingling in the skin, particularly with malaria caused by P. falciparum . Complications of malaria ...
Vomiting in Biological Dictionary

Bile

... - Definition of Bile at Dictionary.com a free online dictionary with ... vomiting bile . Relax. Take A Deep Breath. vomiting bile . www.RightHealth.com ... A variety of diseases can affect your ...

Colchicine

... ? ... Schlesinger N, Schumacher R, Catton M, Maxwell L. Colchicine for acute gout. ... Colchicine may cause side effects such as nausea, vomiting and diarrhea. ... ...
Other Contents
(Date:8/1/2015)... In (PRWEB) , ... August 02, 2015 , ... ... month which will help the continuity of care for patients at this natural health ... of the unknown," Clinic Director Mary Heal said. "Heather's role is vital to our ...
(Date:8/1/2015)... , ... August 01, 2015 , ... The condition where ... both men and women often causing pain and discomfort. Those who spend a lot ... problem, and Northeast Houston Vein Center is doing what it can to create awareness ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... ... Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & Wellness ... into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy ...
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was ... the latest and coolest applications on the market for iOS, Android, and Windows. Joe ... with viewers allows users to clarify, edit and delete any message including ones already ...
(Date:7/31/2015)... New York (PRWEB) , ... July 31, 2015 , ... ... strut their stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) ... trademark application in process. , To commemorate introduction of this new type of sod, ...
Breaking Medicine News(10 mins):Health News:New Patient Advocate Enhances Natural Health Care 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
(Date:7/31/2015)... , July 31, 2015 The 10 th ... be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th anniversary this ... of the world,s most influential annual meetings in the ,omics, ... enjoyable scientific gatherings. ICG-10 focuses on recent ...
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
(Date:7/21/2015)... , July 21, 2015 Today, ZTE announced ... received as well as expected revenues in 2015 that relate to ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ... a leading smartphone manufacturer in China and ... 02 5 for Axon , ...
Breaking Biology News(10 mins):The 10th International Conference on Genomics (ICG-10) to Open in October 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
Other TagsOther Tags